Synthesis,Characterization, and Crystal Structures of Oxidovanadium(V) Complexes Derived from 2-Chloro-N'-(3,5-dichloro-2-hydroxybenzylidene)benzohydrazide with Antimicrobial Activity

Russian Journal of Coordination Chemistry - Two new oxodovanadium(V) complexes, [VO(L)(OEt)(MeOH)] (I) and [VO(L)(Bha)] · EtOH (II), where L is the anion of...     

Synthesis and Crystal Structure of 4-Nitro-2- [（2-diethylaminoethylimino）methyl]phenol

1 INTRODUCTION Schiff base ligands have played an important role in the development of coordination chemistry as they readily form stable complexes with most metal ions[1～4]. These complexes are very interesting in many fields, such as catalysis and enzymatic reac- tions[5, 6], magnetism and molecular architectures[7～9]. The complexes derived from the similar tridentate Schiff base ligand 2-[(2-dimethylaminoethylimino)- methyl]phenol[10, 11] and its derivatives[12～14] have been widely …     

Synthesis, Crystal Structure and Fungicidal Activity of (E)-2-[(4-tert-Butyl-5- (4-methoxybenzyl)thiazol-2-ylimino)methyl]phenol

The title compound(E)-2-(4-tert-butyl-5-(4-methoxybenzyl)thiazol-2-ylimino)me-thylphenol was synthesized by the reaction of 5-(4-methoxybenzyl)-4-tert-butylthiazol-2-amine with salicylaldehyde=and its crystal structure was determined by single-crystal X-ray diffraction.The crystal belongs to the monoclinic system=space group P21/c with a=5.9362(8)=b=11.5070(15)=c=29.460(4)=β=97.326(3)°=V=1995.9(5)3=Z=4=F(000)=808=C22H24N2O2S=Mr=380.49=Dc=1.266 g/cm3=S=1.031=μ=0.181 mm--1=the final R=0.0474 and wR=0.1441 for 4327 observed reflections(I > 2σ(I)).Intramolecular O-H…N hydrogen bond is observed in the crystal.The preliminary bioassay showed that the title compound exhibits 95% inhibition rate against Rhizoctonia solani at the test concentration of 500 mg/L.     

Synthesis,Characterization, Crystal Structures and Antimicrobial Activity of Oxidovanadium(V) Complexes with Mixed Ligands

Russian Journal of Coordination Chemistry - Two new oxidovanadium(V) complexes, [VOLL1] (I) and [VOLL2] (II), where L is the dianionic form of the hydrazone ligand...     

Synthesis, Crystal Structure and Antibacterial Activity of Two Hydrazones Derived from 2-Fluorobenzhydrazide

Two new Schiff base benzoyl hydrazone compounds, C14H10FN3O3 (Ⅰ) and C14H10F2N2O (Ⅱ), have been synthesized and characterized by elemental analysis, IR, UV and X-ray single-crystal diffraction. Both compounds crystallize in monoclinic, space group P21/c with a = 7.0514(14), b = 25.928(5), c = 7.7099(15), β = 111.823(2)°, V = 1308.6(4)3, Z = 4, C14H10FN3O3, Mr = 287.25, Dc = 1.458 g/cm3, μ(MoKα) = 0.115 mm-1, F(000) = 592, the final R = 0.0841 and wR = 0.2489 for 1901 observed reflections (I > 2σ(I)) for I; a = 11.232(3), b =12.735(4), c = 8.612(2) , β = 90.869(3)°, V = 1231.7(6)3, Z = 4, C14H10F2N2O, Mr = 260.24, Dc = 1.403 g/cm3, μ(MoKα) = 0.111 mm-1, F(000) = 536, the final R = 0.0453 and wR = 0.1085 for 1317 observed reflections (I > 2σ(I)) for Ⅱ. The antibacterial activities of both compounds against two bacteria were first studied and one compound showed considerable antibacterial activity against K. Pneumonia and S. aureus.     

基于2-(4-苯基-1,2,3-三唑)亚甲基吡啶(PTMP)的过渡金属配合物的合成与晶体结构

本文报道了一类基于 2-(4-苯基-1,2,3-三唑)亚甲基吡啶(PTMP)配体的过渡金属镍、钴和锌配合物的合成,并通过单晶衍射实验确定了它们的晶体结构。研究结果表明,在这类金属配合物中,PTMP 均通过吡啶氮原子和 1,2,3-三唑中的 2 位氮原子与金属配位,并形成了六元螯合环。在 Co髤及 Ni髤的配合物中,有 2 个 PTMP 参与配位,配位数为 6,配合物的空间构型是畸变的八面体;而在 Zn髤中则只有 1 个 PTMP 参与配位,配位数为 4,配合物的空间构型是变形的四面体。晶体结构数据分析及理论计算结果表明,尽管 PTMP 分子中 1,2,3-三唑环上的 2 位氮原子相对于 3 位氮原子而言,电子云密度较低,但在这类配合物中由于"螯合效应"2 位氮原子仍然表现出了较强的配位能力。     

Synthesis,Crystal Structure and Antimicrobial Property of 4-Bromo- 2- [（3-methypyridin-2-ylimino）methyl]phenol

The title Schiff base compound 4-bromo-2-[（3-methylpyridin-2-ylimino）methyl]phenol was prepared and structurally characterized by elemental analysis, IR spectrum, and single-crystal X-ray diffraction. The crystal belongs to monoclinic, space group P2 1/n, with a = 4.4870（9）, b = 19.953（4）, c = 13.860（3）A, β = 93.13（3）°, V = 1239.0（4）A3 Z = 4, Dc = 1.561 g/cm3, C13H11BrN2O2 , Mr = 291.15, p = 3.302 mm-1 and F（000） = 584. The final refinement gave R = 0.0608 and wR = 0.1377 for 1329 observed reflections with I 〉 2σ（I）. X-ray diffraction reveals that the non-hydrogen atoms in the compound are nearly coplanar, with the mean deviation of 0.0197A from the plane. The molecule adopts an E configuration about the central C=N functional bond. The compound possesses moderate antimicrobial property.     

Synthesis,Crystal Structure and Antimicrobial Property of 4-Bromo-2-[(3-methypyridin-2-ylimino)methyl]phenol

The title Schiff base compound 4-bromo-2-[(3-methylpyridin-2-ylimino)me-thyl]phenol was prepared and structurally characterized by elemental analysis,IR spectrum,and single-crystal X-ray diffraction.The crystal belongs to monoclinic,space group P21/n,with a=4.4870(9),b=19.953(4),c=13.860(3)(A),β=93.13(3)°,V=1239.O(4)(A)3,Z=4,Dc=1.561g/cm3,C13H11BrN2O2,Mr=291.15,μ=3.302mm-1 and F(000)=584.The final refinement gave R =0.0608 and wR=0.1377 for 1329 observed reflections with I＞2σ(I).X-ray diffraction reveals that the non-hydrogen atoms in the compound are nearly coplanar,with the mean deviation of 0.0197 (A) from the plane.The molecule adopts an E configuration about the central C=N functional bond.The compound possesses moderate antimicrobial property.     

Synthesis, Crystal Structure and Antibacterial Activities of 3-[（2-Hydroxy-4-diethylamino-phenyl）methylenehydrazinocarbonyl]-4-hydroxy-6-methyl-2（1H）-pyridinones

1 INTRODUCTION Recently, compounds containing pyrazole, imida- zole, triazole (including benzotriazole), pyridine, tetrazole and indole have attracted much interest because of their fungicidal activity, plant-growth regulating activity and antibacterial activity[1～3]. Schiff bases also constitute a good type of biolo- gically active substructures[4～7]. Studies of pyri- dine Schiff base-type fungicides have been repor- ted[8]. However, some structures of pyridine com- pounds containing h…     

Synthesis,Characterization and Crystal Structures of Oxidovanadium(V) and Dioxidomolybdenum(VI) Complexes Derived from 2-bromo-N'-(2-hydroxy-3-methoxybenzylidene)benzohydrazide with Catalytic Property

Russian Journal of Coordination Chemistry - A hydrazone compound 2-bromo-N'-(2-hydroxy-3-methoxybenzylidene)benzohydrazide (H2L) was prepared and characterized by IR, UV-Vis and NMR spectra....     

Synthesis,Crystal Structure,and Cytotoxic Property of Dibromobis{4-bromo-2-[（2- phenylaminoethylimino）methyl]phenolato}dizinc（II）

The title phenolic oxygen bridged dinuclear Schiff base zinc（II） complex [Zn2Br2- （C15H14BrN2O）2] was synthesized and characterized by elemental analysis and single-crystal X-ray diffraction. The crystal belongs to the triclinic system, space group P1 with a = 9.2279（17）, b = 12.096（2）, c = 16.286（3） A, α = 75.402（3）, β = 87.464（3）, γ= 72.746（3）°, V = 1679.1（5） A^3, Z = 2, Dc = 1.833 g/cm^3, Mr = 926.94, λ（MoKα） = 0.71073 A, μ= 6.221 mm^-1, F（000） = 904, the final R = 0.0601 and wR = 0.1155. A total of 7453 unique reflections were collected, of which 3425 with I 〉 2σ（I） were observed. One Zn atom is six-coordinate in an octahedral geometry, and the other one is four-coordinate in a tetrahedral geometry. The Zn...Zn distance is 3.106（2） A. In the crystal structure, molecules are linked through intermolecular hydrogen bonds typed N-H...Br and C-H...Br, forming zigzag chains running along the b axis. The complex shows potent cytotoxic property to both normal and carcinoma cells.     

Synthesis,Bioactivity and Crystal Structure Analysis of Diisopropyl[（4-cyanopyrazol-3-ylamino）（2-hydroxyl-phenyl） methyl]phosphonate

The title compound,diisopropyl[(4-cyanopyrazol-3-ylamino)(2-hydroxylphenyl) -methyl] phosphonate was synthesized by the addition reaction of diisopropyl phosphite and N-(4-cyanopyrazole-3-yl) -2-hydroxylphenyl-imine. Its structure was characterized by IR,1H NMR,elemental analysis and single-crystal X-ray diffraction. The crystal belongs to the triclinic system,space group P1 with a = 9.1840(13) ,b = 9.2278(13),c = 12.1952(17) ,α = 93.846(2) ,β = 90.947(2) ,γ = 111.289(2) °,V = 959.9(3) 3,Dc = 1.309 g/cm3,Z = 2,μ(MoKa) = 0.173,F(000) = 400,the final R = 0.0414 and wR = 0.1196 for 2985 observed reflections(I > 2σ(I)) . The pyrazole and benzene moieties are approximately coplanar in each case. The dihedral angle between planes 1 and 2 is 82.99°. The crystal structure is stabilized by three intermolecular hydrogen bonds of O(1) -H(1) …O(2) ,N(2) -H(2) …N(3) and N(2) -H(2) …O(1) . Preliminary bioassay indicated that the title compound possessed antiviral activity to some extent.     

2-氨基苯并噻唑配合物的晶体结构及抑菌活性

合成了2-氨基苯并噻唑与钴和锌的两种金属配合物,利用红外光谱、元素分析、X射线单晶衍射和热重分析等对其结构进行了表征;并研究了两种金属配合物对金黄色葡萄球菌、大肠杆菌、酵母菌的抑菌活性.结果表明,Zn(Ⅱ)和Co(Ⅱ)分别与2个O原子和2个N原子通过4配位形成扭曲的四面体构型;两种配合物对三种菌种均有较强的选择性抑制作用.     

Synthesis,Crystal Structure and Biological Activity of 2-[(Pyridin-2-yl)methylthio]-1H-benzimidazole Derivatives

In order to discover the novel anti-tumor agents, a series of 2-[(pyridin-2-yl)methylthio]-1 H-benzimidazole derivatives were designed and synthesized, and the structures were characterized by IR, MS, and proton NMR. 2-[(3,4-Dimethoxypyridin-2-yl)methylthio]-1 Hbenzimidazole was investigated with X-ray crystallography, and the molecule is in orthorhombic system, space group P212121, with a = 9.1828(16), b = 11.625(2), c = 13.463(2) ?, Z = 4, R = 0.0231 and wR = 0.0596. The antitumor activities of target compounds were evaluated against human liver cancer cell line HepG2, and human liver normal cell line HL7702 using MTT assay. The target compounds have demonstrated weak or moderate anti-tumor activity against HepG2, while all the target compounds exhibit no cytotoxic effects on HL7702.     

二正丁基锡二2-(2-甲酰基苯氧基)乙酸酯的合成、晶体结构及杀菌活性

在苯溶液中,将2-(2-甲酰基苯氧基)乙酸与二正丁基氧化锡进行脱水反应,获得二正丁基锡二2-(2-甲酰基苯氧基)乙酸酯(1),并经过元素分析、1H NMR和IR及晶体结构测试技术进行了结构表征。结果表明,晶体属于C2/c空间群,晶胞参数:a=3.324 6(7)nm,b=0.484 54(10)nm,c=2.214 7(5)nm,β=131.373(2)°,V=2.677 3(9)nm3,Z=4,F(000)=1 208,Dc=1.467 g/cm3,μ=0.999 mm-1,R1=0.048 8,wR2=0.104 8。结构单元内包含1个独立分子,形成以六配位锡为中心的斜梯形双棱锥构型;分子间的Sn O(0.346 8 nm)配位作用,中心锡原子为八配位,构成以锡为中心的扭曲的六方双锥构型的一维链状桥环化合物。杀菌活性顺序为:化合物1>二丁基氧化锡>2-(2-甲酰基苯氧基)乙酸。     

离子化合物{[2-(3′-pyridyl)benzimidazoleH2]2+·[SbCl4]-·Cl-}4的水热合成、晶体结构及抑菌活性

A new ionic compound {[2-(3′-pyridyl)benzimidazoleH₂]²⁺·[SbCl₄]^-·Cl^-}₄ was synthesized by the hydrothermal reaction of o-diaminobenzene, nicotinic acid with SbCl₃ in 1∶1 HCl solution. The structure was characterized by chemical analysis, elemental analysis and IR patterns. The single crystal structure was determined by X-ray single crystal diffraction. It crystallizes in monoclinic system, space group P2₁/n with a=2.107 9(4) nm, b=1.482 0(3) nm, c=2.113 4(4) nm, β=93.44(3)°, Z=4, V=6.590(2) nm³, D_c=2.001 g·cm^-3, μ=2.480 mm^-1, F(000)=3840, R₁=0.0468, wR₂=0.1163. The single crystal structure indicates that the four chlorines coordinated to the antimony atom forms a distorted triangle bipyramid configuration together with the lone electron pair on the Sb atom. The [SbCl₄]^- to 2-(3′-pyridyl)benzimidazole cation and Cl^- by weak interaction forms the ionic crystal. It has been proved that the title compound has antibacterial activity. CCDC: 283824.     

Synthesis and Crystal Structure of （Z）-Methyl-3-methoxy-2-{2-[（4-（E-3-p-tolylacryloyl）phenoxy）methyl]phenyl}acrylate

The title compound,(Z)-methyl-3-methoxy-2-{2-[(4-(E-3-p-tolylacryloyl)phenoxy)-methyl]phenyl}acrylate,was synthesized and determined by X-ray single-crystal diffraction. The crystal belongs to the triclinic system,space group P1 with a = 8.0157(8),b = 12.5748(13),c = 13.3768(14) ,α = 64.770(2),β = 75.720 (2),γ = 89.784(2)°,μ = 0.085 mm-1,Mr = 442.49,V = 1174.1(2) 3,Z = 2,Dc = 1.252 g/cm3,F(000) = 468,T = 294(2) K,R = 0.0603 and wR = 0.1498 for 2644 observed reflections with I 2σ(I). X-ray diffraction analysis reveals that the single crystal contains strong non-classical hydrogen bonds. The preliminary bioassay showed that the title compound exhibits inhibitory activity against the Pseudoperoniospora cubensis and Rhizoctonia solani at the test concentration of 200 mg/L.     

Synthesis,Crystal Structure and Anti-integrase Activity of 25,27-Bis[(Z)-4-(p-methoxyphenyl)-4-hydroxybut-3-en-2-one-1-methyl]-26,28-dihydroxycalix [4] arene

The title compound(C50H44O10) was synthesized and structurally determined by single-crystal X-ray diffraction method. It crystallizes in monoclinic, space group P21/c with a = 16.713(4), b = 13.189(3), c = 19.434(5) , β = 104.411(4)°, Mr = 804.85, Dc = 1.288 g/cm3, V = 4149.2(17) 3, Z = 4, F(000) = 1696, μ(MoKa) = 0.089 mm-1, T = 296(2) K, 7279 independent reflections with 3172 observed ones(I 2σ(I)), R = 0.0520 and wR = 0.1203 with GOF = 0.928(R = 0.1464 and wR = 0.1657 for all data). The calixarene moiety maintains the symmetric cone conformation through intramolecular O–H···O hydrogen bonds. Preliminary bioassays indicated that the title compound has a potent inhibitory activity against the strand transfer process of HIV-1 integrase.